Prospective Evaluation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder

Journal of Urology

Volumn 179, Issue 6, 2008, Pages 2164-2169

  Lotan, Yair ^a   Bensalah, Karim ^a   Ruddell, Timothy ^a   Shariat, Shahrokh F ^a   Sagalowsky, Arthur I ^a   Ashfaq, Raheela ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

bladder; carcinoma; cytology; fluorescence; in situ hybridization; transitional cell; urothelium

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; CYTOLOGY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; URINARY TRACT CARCINOMA; UROTHELIUM;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 43049126455     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.01.105     Document Type: Article

References (18)

1. Schneeweiss S., Kriegmair M., and Stepp H. Is everything all right if nothing seems wrong?. A simple method of assessing the diagnostic value of endoscopic procedures when a gold standard is absent. J Urol 161 (1999) 1116
2. Hungerhuber E., Stepp H., Kriegmair M., Stief C., Hofstetter A., Hartmann A., et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69 (2007) 260
3. Svatek R.S., Lee D., and Lotan Y. Correlation of office-based cystoscopy and cytology with histologic diagnosis: how good is the reference standard?. Urology 66 (2005) 65
4. Grossman H.B., Messing E., Soloway M., Tomera K., Katz G., Berger Y., et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA 293 (2005) 810
5. Paez A., Coba J.M., Murillo N., Fernandez P., de la Cal M.A., Lujan M., et al. Reliability of the routine cytological diagnosis in bladder cancer. Eur Urol 35 (1999) 228
6. Raitanen M.P., Aine R., Rintala E., Kallio J., Rajala P., Juusela H., et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 41 (2002) 284
7. Nabi G., Greene D.R., and O'Donnell M. How important is urinary cytology in the diagnosis of urological malignancies?. Eur Urol 43 (2003) 632
8. Nabi G., Greene D., and O'Donnell M.O. Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?. J Clin Pathol 57 (2004) 365
9. Raitanen M.P., Aine R., Kylmala T., Kallio J., Liukkonen T., and Tammela T. The dilemma of suspicious urine cytology in patients being followed for bladder cancer. Ann Chir Gynaecol 90 (2001) 256
10. Lotan Y., and Roehrborn C.G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta- analyses. Urology 61 (2003) 109
11. Halling K.C., King W., Sokolova I.A., Meyer R.G., Burkhardt H.M., Halling A.C., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164 (2000) 1768
12. Sarosdy M.F., Kahn P.R., Ziffer M.D., Love W.R., Barkin J., Abara E.O., et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol 176 (2006) 44
13. Skacel M., Fahmy M., Brainard J.A., Pettay J.D., Biscotti C.V., Liou L.S., et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169 (2003) 2101
14. Yoder B.J., Skacel M., Hedgepeth R., Babineau D., Ulchaker J.C., Liou L.S., et al. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings. Am J Clin Pathol 127 (2007) 295
15. Daniely M., Rona R., Kaplan T., Olsfanger S., Elboim L., Zilberstien Y., et al. Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples. Urology 66 (2005) 1354
16. Veeramachaneni R., Nordberg M.L., Shi R., Herrera G.A., and Turbat-Herrera E.A. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 28 (2003) 301
17. Mian C., Maier K., Comploj E., Lodde M., Berner L., Lusuardi L., et al. uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses. Cancer 108 (2006) 60
18. Pfister C., Chautard D., Devonec M., Perrin P., Chopin D., Rischmann P., et al. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. J Urol 169 (2003) 921